Fact sheet: Parvest EqWdHthCre

Fund information

Fund name
Parvest Equity World Health Care Classic Cap EUR
Fund company manager
BNP Paribas Asset Management L
Fund type
SIB
Fund manager
Jon Stephenson
since 02/05/2016
Fund objective
Increase the value of its assets over the medium term.
Benchmark
MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

0.78 %

1 Year rank in sector

26/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 311.3 m

FE Risk score

147

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    76.58%
  • Switzerland
    8.2%
  • UK
    7.52%
  • Germany
    5.89%
  • Japan
    1.27%
  • Pharmaceuticals
    42.9%
  • Biotechnology/Medical
    26.64%
  • Healthcare & Medical Products
    15.96%
  • Health Care
    14.5%
  • US Equities
    76.58%
  • Swiss Equities
    8.2%
  • UK Equities
    7.52%
  • German Equities
    5.89%
  • Japanese Equities
    1.27%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund2.32 %-3.54 %0.78 %18.42 %87.3 %
Sector2.44 %5.7 %6.98 %21.14 %97.17 %
Rank within sector19 / 3029 / 3026 / 2915 / 2715 / 23
Quartile th3 rd4 th4 th3 rd3 rd

Calendar performance

YTD-20172016201520142013
Fund2.35 %-8.75 %15.07 %34.91 %31.67 %
Sector15.5 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector28 / 2913 / 295 / 2710 / 2418 / 23
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha-0.2
Beta1.02
Sharpe0.2
Volatility17.47
Tracking error7.53
Information ratio-0.04
R-Squared0.81

Price movement

52 week high995.53
52 week low804.23
Current bid price0
Current offer price0
Current mid price913.37

Holdings by region

  • 76.58% USA
  • 8.2% Switzerland
  • 7.52% UK
  • 5.89% Germany
  • 1.27% Japan
  • 0.54% Ireland

Holdings by sector

  • 42.9% Pharmaceuticals
  • 26.64% Biotechnology/Medical
  • 15.96% Healthcare & Medical Products
  • 14.5% Health Care

Holdings by asset type

  • 76.58% US Equities
  • 8.2% Swiss Equities
  • 7.52% UK Equities
  • 5.89% German Equities
  • 1.27% Japanese Equities
  • 0.54% Irish Equities

Individual holdings

  • 7.25% UNITEDHEALTH GROUP INC
  • 6.52% CELGENE CORP
  • 5.92% ALLERGAN INC
  • 5.09% MERCK & CO INC(NEW)
  • 5.03% BRISTOL MYERS SQUIBB SA
  • 4.88% BOSTON SCIENTIFIC CORP
  • 4.46% EDWARDS LIFESCIENCES CORP
  • 4.1% JAZZ PHARMACEUTICALS PLC
  • 3.98% NOVARTIS AG
  • 3.67% CENTENE CORP(DEL)